July 25, 2024

Vancouver, Jan. 02, 2024 (GLOBE NEWSWIRE) — The global clinical nutrition market exhibited a strong performance in 2022 with a market size reaching USD 47 Billion, and it is anticipated to experience a rapid revenue Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period. Key drivers include the increasing prevalence of metabolic disorders, lifestyle-related chronic diseases, premature births, malnutrition due to high junk food consumption, and a growing geriatric population globally. Additionally, the adoption of home healthcare and advancements in clinical nutrition, such as plant-based and personalized products, contribute to the market’s growth.

Clinical nutrition has evolved significantly in the twenty-first century, offering novel techniques for health regulation through diet. Advances in clinical nutrition products, integration of technological innovations, and shifting customer expectations contribute to the market’s revenue growth. Clinical nutrition formulations play a vital role in addressing various ailments, including Gastrointestinal (GI) illnesses, cancer, liver diseases, and swallowing difficulties.

Malnutrition, a major concern globally, is driving the demand for clinical nutrition supplements. According to the World Health Organization (WHO), millions of children suffer from stunting, wasting, or being overweight. Major nutrition food manufacturers are addressing this issue, with initiatives like Bayer’s Nutrient Gap Initiative aimed at fighting malnutrition and improving access to nutritious food for 50 million people by 2030.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2643 

Neurodegenerative diseases, cancer, and metabolic disorders are on the rise, further propelling the demand for clinical nutrition products. Companies like Esperer Onco Nutrition are innovating to provide nutrition supplements tailored to cancer patients’ needs. Research and Development (R&D) activities focus on improving dietary supplements for chronic diseases, leading to the availability of functional foods and nutraceuticals in the market.

However, challenges such as lack of awareness about medical nutrition, stringent government regulations, and product recalls pose potential restraints. For example, the Food and Drug Administration (FDA) issued recalls due to undeclared allergens in some dietary supplement products, emphasizing the need for strict quality control.

Product Type Insights: The amino acid solutions segment dominated the global clinical nutrition market in 2022, driven by the increasing demand for protein concentrate. Protein supplements, like Glanbia Nutritionals’ FerriUp, are addressing the needs of fitness enthusiasts and those with nutritional disorders. The multiple vitamins segment is expected to show steady growth due to the rising prevalence of vitamin deficiency, with Centrum launching multivitamins tailored for different demographics.

Application Insights: The pediatric malnutrition segment is poised to hold a significant revenue share, with companies like Abbott introducing innovative solutions like PediaSure to support children’s growth and development. The metabolic disorders segment is anticipated to grow steadily, addressing the increasing prevalence of metabolic conditions like Phenylketonuria (PKU) through products like Galen Medical Nutrition’s PKU EASY Microtabs.

Consumers Insights: The sports person segment is expected to lead in revenue share, driven by the rising demand for sports nutrition. Lonza’s TWK10 sports nutrition, featuring a probiotic strain, exemplifies the industry’s focus on providing comprehensive nutrition for active individuals.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2643

Regional Insights: North America accounted for the largest revenue share, with the United States facing nutrition-related health crises, particularly in children. Initiatives like PLEZi Nutrition and strategic partnerships, such as Pendulum Therapeutics with Fonterra, are contributing to the region’s growth. Europe is expected to witness the fastest growth, propelled by government regulations, start-ups focusing on clinical nutrition, and major players like Nestlé introducing plant-based alternatives. The Asia Pacific region is forecasted to have a considerable revenue share, driven by government initiatives, a growing geriatric population, and advancements in healthcare infrastructure.

Scope of Research

Report Details Outcome
Market Size in 2022 USD 47 Billion
CAGR (2023–2032) 5.3%
Revenue Forecast To 2032 USD 78.77 Billion
Base Year For Estimation 2022
Historical Data 2019-2021
Forecast Period 2023–2032
Quantitative Units Revenue in USD Million and CAGR in % from 2023 to 2032
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered product type, application, route of administration, dosage formulation, distribution channels, consumers, and region
Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Country Scope U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa
Key Companies Profiled Pfizer Inc., Abbott., Lonza’s Capsules & Health Ingredients (CHI), Nestlé, Perrigo Company plc., Hero Nutritionals, Baxter, Sanofi, Reckitt Benckiser Group PLC, Mead Johnson & Company, B. Braun SE, Danone, Fresenius SE & Co. KGaA, AYMES Nutrition, Medifood International SA, Ajinomoto Co., Inc., Bayer AG, Grifols, S.A., BASF Corporation, Zeon Lifesciences Ltd., Nutrimed Healthcare, Zenova Bio Nutrition, Bionova, Nutra Healthcare Pvt Ltd, Lifecare Neuro Products Limited, and Meiji Holdings Co., Ltd.
Customization Scope 10 hours of free customization and expert consultation

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2643

Major Companies and Competitive Landscape

The global clinical nutrition market is fairly fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective clinical nutrition solutions in the market. Some major players included in the global clinical nutrition market report are:

  • Pfizer Inc.
  • Abbott
  • Lonza’s Capsules & Health Ingredients (CHI)
  • Nestlé
  • Perrigo Company plc.
  • Hero Nutritionals
  • Baxter
  • Sanofi
  • Reckitt Benckiser Group PLC
  • Mead Johnson & Company
  • B. Braun SE
  • Danone
  • Fresenius SE & Co. KGaA
  • AYMES Nutrition
  • Medifood International SA
  • Ajinomoto Co., Inc.
  • Bayer AG
  • Grifols, S.A.
  • BASF Corporation
  • Zeon Lifesciences Ltd.
  • Nutrimed Healthcare,
  • Zenova Bio Nutrition
  • Bionova
  • Nutra Healthcare Pvt Ltd.
  • Meiji Holdings Co., Ltd.
  • Lifecare Neuro Products Limited

Strategic Development

  • On 8 May 2023, Corbion, a supplier of algae-based feed ingredients, announced the debut in human nutrition industry by launch of AlgaVia line of products, which is rich in omega-3 and omega-9 fatty acids as nutritious supplements. These supplements are developed through algal fermentation with a purpose to decrease pressure on marine resources as well as carbon footprint associated with the production of dietary supplements.

Segments Covered in Report

For the purpose of this report, Emergen Research has segmented the global clinical nutrition market on the basis of product type, application, route of administration, dosage formulation, distribution channels, consumers, and region:

  • Product Type Outlook (Revenue, USD Billion; 2019-2032)
    • Amino Acid Solutions
    • Multiple Vitamins
    • Antioxidants
    • Lipid Emulsions
    • Trace Elements
    • Chamber Bags
  • Application Outlook (Revenue, USD Billion; 2019-2032)
    • Pediatric Malnutrition
    • Metabolic Disorders
    • Cancer
    • Neurological Diseases
    • Gastrointestinal Diseases
    • Other (Diabetes, Renal Failure, and Pulmonary Diseases)
  • Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
  • Dosage Formulation Outlook (Revenue, USD Billion; 2019-2032)
  • Distribution Channel Outlook (Revenue, USD Billion; 2019-2032)
    • Hospitals
    • Pharmacy and Drug Stores
    • Online Pharmacy
    • Others
  • Consumers Outlook (Revenue, USD Billion; 2019-2032)
    • Infants/ Pediatric
    • Sportsperson
    • Adults
    • Geriatric
  • Regional Outlook (Revenue, USD Billion; 2019-2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. UK
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of Middle East & Africa

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/clinical-nutrition-market 

Curated Reports You Shouldn’t Miss: Dive In Now!

Bowel Management Systems Market, By Product (Colostomy Bags, Irrigation Systems, and Others), By Patient Type (Adult, Pediatric, and Others), By Region Forecast to 2032

Cardiac Mapping Market, By Product (Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems), By Indication, By End-Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Diagnostic Centers), and by Region Forecast to 2032

Diabetes Care Devices Market, By Type (Blood Glucose Monitoring Systems, Lancets, and Insulin Delivery Devices), By Patient Care Settings (Hospital & Clinics and Diabetes Specialty Clinics), and By Region Forecast to 2032

Wound Dressings Market, By Product Type (Advanced and Traditional), By Wound Type (Surgical & Traumatic Wound and Pressure Ulcers), By End-use [Hospital & Clinics, Ambulatory Surgical Centers (ASCs)], and by Region Forecast to 2032

Patient Lateral Transfer Market, By Product Type (Air-Assisted Lateral Transfer Mattress, Sliding Sheets, Accessories), By Usage (Reusable Mattresses, Sliding Sheet), By End-use (Hospitals, ASCs), By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights


Leave a Reply

Your email address will not be published. Required fields are marked *